KNSA Kiniksa Pharmaceuticals International, plc
Nasdaq · SEC CIK 1730430 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $61.90M 29 sales by 8 insiders
- Filings on record
- 268 since 2021-07-01, latest 2026-09-03 16:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Patel Sanj K | COB, CEO, Dir | — | $39.43M |
| Paolini John F. | Chief MEDICAL Off | — | $8.00M |
| Ragosa Mark | CFO | — | $5.56M |
| Tessari Eben | Chief STRATEGY Off | — | $3.10M |
| Quart Barry D | Dir | — | $2.68M |
| Megna Michael R | CAO | — | $2.64M |
| Cole G Bradley | Dir | — | $299.1K |
| Moat Ross | COO | — | $194.5K |
| McCain Tracey L | Dir | — | — |
| Levy Richard S | Dir | — | — |
Transactions 443
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-06 | 2022-07-15 | KNSA | Tessari Eben | COO | A - Grant | $9.56 | +1,048 | 113.3K | +0.9% | +$10.0K |
| D | 2022-09-06 | 2022-09-02 | KNSA | Tessari Eben | COO | F - Tax | $11.44 | -577 | 114.6K | -0.5% | -$6,601 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Tessari Eben | COO | M - OptEx | — | +1,964 | 115.2K | +2% | — |
| D | 2022-09-06 | 2022-09-02 | KNSA | Megna Michael R | CAO | M - OptEx | — | +775 | 7,519 | +11% | — |
| D | 2022-09-06 | 2022-07-15 | KNSA | Megna Michael R | CAO | A - Grant | $9.56 | +703 | 6,744 | +12% | +$6,721 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Megna Michael R | CAO | F - Tax | $11.44 | -228 | 7,291 | -3% | -$2,608 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | — | +1,725 | 36.8K | +5% | — |
| D | 2022-09-06 | 2022-09-02 | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $11.44 | -507 | 36.3K | -1% | -$5,800 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,569 | 24.3K | +37% | — |
| D | 2022-09-06 | 2022-09-02 | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $11.44 | -1,929 | 22.4K | -8% | -$22.1K |
| D | 2022-09-06 | 2022-07-15 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $9.56 | +360 | 7,732 | +5% | +$3,442 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +995 | 8,727 | +13% | — |
| D | 2022-09-06 | 2022-09-02 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $11.44 | -563 | 8,164 | -6% | -$6,441 |
| DMI | 2022-06-30 | 2022-06-29 | KNSA | Baker Bros. Advisors (GP) LLC | Dir | A - Grant | $0.00 | +20.0K | 109.0K | +22% | $0 |
| D | 2022-04-28 | 2022-04-26 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +991 | 6,639 | +18% | — |
| D | 2022-04-28 | 2022-04-26 | KNSA | Ragosa Mark | CFO | F - Tax | $9.99 | -282 | 6,357 | -4% | -$2,817 |
| D | 2022-03-23 | 2022-03-21 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +3,019 | 6,695 | +82% | — |
| D | 2022-03-23 | 2022-03-21 | KNSA | Ragosa Mark | CFO | F - Tax | $10.98 | -1,047 | 5,648 | -16% | -$11.5K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $10.98 | -5,446 | 17.8K | -23% | -$59.8K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +18.6K | 23.2K | +399% | — |
| D | 2022-03-23 | 2022-03-21 | KNSA | Megna Michael R | CAO | F - Tax | $10.98 | -1,120 | 6,041 | -16% | -$12.3K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Megna Michael R | CAO | M - OptEx | — | +3,231 | 7,161 | +82% | — |
| D | 2022-03-23 | 2022-03-21 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | — | +5,676 | 36.8K | +18% | — |
| D | 2022-03-23 | 2022-03-21 | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $10.98 | -1,686 | 35.1K | -5% | -$18.5K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Tessari Eben | COO | F - Tax | $10.98 | -1,461 | 112.2K | -1% | -$16.0K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Tessari Eben | COO | M - OptEx | — | +4,611 | 113.7K | +4% | — |
| D | 2022-03-23 | 2022-03-21 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +2,270 | 8,612 | +36% | — |
| D | 2022-03-23 | 2022-03-21 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $10.98 | -1,240 | 7,372 | -14% | -$13.6K |
| D | 2022-03-18 | 2022-03-16 | KNSA | Ragosa Mark | CFO | F - Tax | $10.13 | -303 | 3,676 | -8% | -$3,069 |
| D | 2022-03-18 | 2022-03-16 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +872 | 3,979 | +28% | — |
| D | 2022-03-18 | 2022-03-16 | KNSA | Moat Ross | Chief Commercial Off | F - Tax | $10.13 | -544 | 6,342 | -8% | -$5,511 |
| D | 2022-03-18 | 2022-03-16 | KNSA | Moat Ross | Chief Commercial Off | M - OptEx | — | +995 | 6,886 | +17% | — |
| DM | 2022-03-18 | 2021-07-15+ | KNSA | Moat Ross | Chief Commercial Off | A - Grant | $10.34 | +2,509 | 5,891 | +74% | +$26.0K |
| D | 2022-03-18 | 2022-03-16 | KNSA | Paolini John F. | Chief Medical Off | M - OptEx | — | +1,725 | 31.7K | +6% | — |
| D | 2022-03-18 | 2022-03-16 | KNSA | Paolini John F. | Chief Medical Off | F - Tax | $10.13 | -598 | 31.1K | -2% | -$6,058 |
| D | 2022-03-18 | 2022-03-16 | KNSA | Tessari Eben | COO | F - Tax | $10.13 | -681 | 109.1K | -0.6% | -$6,899 |
| D | 2022-03-18 | 2022-03-16 | KNSA | Tessari Eben | COO | M - OptEx | — | +1,964 | 109.7K | +2% | — |
| DM | 2022-03-18 | 2021-07-15+ | KNSA | Tessari Eben | COO | A - Grant | $10.51 | +1,838 | 106.8K | +2% | +$19.3K |
| DM | 2022-03-18 | 2020-06-30+ | KNSA | Megna Michael R | CAO | A - Grant | $11.03 | +2,287 | 2,771 | +473% | +$25.2K |
| D | 2022-03-18 | 2022-03-16 | KNSA | Megna Michael R | CAO | M - OptEx | — | +775 | 4,199 | +23% | — |
| D | 2022-03-18 | 2022-03-16 | KNSA | Megna Michael R | CAO | F - Tax | $10.13 | -269 | 3,930 | -6% | -$2,725 |
| D | 2022-03-18 | 2022-03-16 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,569 | 6,569 | New | — |
| D | 2022-03-18 | 2022-03-16 | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $10.13 | -1,922 | 4,647 | -29% | -$19.5K |
Purchase Sale Sale after option exercise All abbreviations